News Live

CARsgen® U.S. Clinical Holds Lifted by FDA

CARsgen Therapeutics

SHANGHAI,Nov. 1,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,

Home Previous 98 99 100 101 102 103 104 Next Tail

10 Items Per Page (Page 101 / 460) Total 4593 Items